(Q57702077)
Statements
Efficacy and safety of rituximab second-line therapy for membranous nephropathy: a prospective, matched-cohort study (English)
Piero Ruggenenti
Maria Chiara Sghirlanzoni
Maddalena Marasà
Alessandra Salerno
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference